Back to Search Start Over

Danaher and Stanford partner on cancer drug screening

Source :
M2 Pharma. July 11, 2024
Publication Year :
2024

Abstract

M2 PHARMA-July 11, 2024-Danaher and Stanford partner on cancer drug screening (C)2024 M2 COMMUNICATIONS Global life sciences and diagnostics company Danaher Corporation (NYSE:DHR) on Thursday announced a research collaboration with [...]

Subjects

Subjects :
Danaher Corp. -- Research agreements
Antineoplastic agents
Cancer -- Diagnosis
Mandatory drug testing
Drugs -- Product/Service Evaluations
Antimitotic agents
Chemistry
Stanford University

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Pharma
Publication Type :
News
Accession number :
edsgcl.800922210

Tools

Authors Abstract Subjects Details